NEUROGENE INC

NGNE is the ticker symbol for Neurogene Inc., a biotechnology company focused on developing gene therapies for rare neurological diseases. The stock represents equity ownership in the company. NGNE trades on the Nasdaq Capital Market under that ticker. For current price, market cap, and other live data, refer to the latest NGNE quote displayed on this page.

Recent price movement for NGNE is shown in the live quote and performance chart on this page. Gene therapy stocks can be sensitive to clinical trial news, regulatory developments, and financing activity, so short-term performance may vary widely. Check the latest NGNE data displayed here for up-to-date returns, trading volume, and price history.

NGNE is a small-cap gene therapy company, and stocks in this sector often experience higher volatility than the broader market. Price swings can be driven by trial updates, financing news, and shifts in biotech sentiment. Historical volatility and daily price ranges are available in the NGNE data on this page; review those figures to gauge recent movement.

Valuation for a clinical-stage gene therapy company like NGNE is typically assessed using cash position, pipeline prospects, and potential market opportunities rather than standard earnings multiples. Traditional metrics such as P/E may be less meaningful if the company is not yet profitable. Review NGNE's balance sheet, cash burn, and pipeline disclosures, and consult the valuation data shown on this page.

Review NGNE's quarterly and annual filings for revenue trends, operating expenses, net loss, and cash position. For a gene therapy company, research and development spending and cash runway are often key indicators. These details are available in NGNE's financial statements and SEC filings; use the financial data on this page to track progress over time.

NGNE does not pay dividends. As a clinical-stage biotechnology company, it typically reinvests capital into research, development, and clinical programs rather than distributing cash to shareholders. Any changes to this policy would be disclosed in NGNE's official filings. Confirm the latest dividend status on the NGNE dividend section of this page.